Cas:146137-85-1 methyl 4-iodo-1-benzothiophene-2-carboxylate manufacturer & supplier

We serve Chemical Name:methyl 4-iodo-1-benzothiophene-2-carboxylate CAS:146137-85-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 4-iodo-1-benzothiophene-2-carboxylate

Chemical Name:methyl 4-iodo-1-benzothiophene-2-carboxylate
CAS.NO:146137-85-1
Synonyms:methyl 4-iodo-1-benzothiophene-2-carboxylate
Molecular Formula:C10H7IO2S
Molecular Weight:318.13100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:54.54000
Exact Mass:317.92100
LogP:3.29250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like methyl 4-iodo-1-benzothiophene-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 4-iodo-1-benzothiophene-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 4-iodo-1-benzothiophene-2-carboxylate Use and application,methyl 4-iodo-1-benzothiophene-2-carboxylate technical grade,usp/ep/jp grade.


Related News: Importance of evaluating biocatalytic processes during development (Z)-(3,3-dihydroxy-13,24,34,43-bicyclo[2.2.1]heptaoxidan-2-ylidene)-11,24,54-hexaoxidan-2-one manufacturers However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. tert-butyl (S)-(2-methyl-1-((5-((2′-((3-methylureido)methyl)-[1,1′-biphenyl]-4-yl)methyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl)amino)-1-oxopropan-2-yl)carbamate suppliers The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22. (R)-3-carbobenzyloxy-amino-1-hydroxysuccinimde vendor & factory.